Haisco Pharmaceutical Group Co., Ltd.
002653
Rang in aandelen
#2092
Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates... Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates within China, focusing on the research, production, and distribution of a diverse range of pharmaceutical products. Their offerings span various dosage forms, including small and large volume injections, freeze-dried and conventional powder injections, and active pharmaceutical ingredients (APIs). These medications target numerous therapeutic areas such as anti-infectives, digestive system disorders, blood system conditions, nervous system ailments, parenteral nutrition, antibiotics, emergency care, anesthesiology, and oncology. Furthermore, the company provides drugs in tablet, capsule, granule, and ointment forms for cardiovascular health, infectious diseases, digestive issues, central nervous system (CNS) conditions, diabetes, and hepatic diseases. Established in 2000 and based in Shannan, China, the company adopted its current name, Haisco Pharmaceutical Group Co., Ltd., in March 2016, having previously been known as Xizang Haisco Pharmaceutical Group Co., Ltd.
Aandeelprijs
$8.64
Marktkapitalisatie
$9.85B
Verandering (1 dag)
4.34%
Verandering (1 jaar)
18.80%
Land
CN
Handel Haisco Pharmaceutical Group Co., Ltd. (002653)
Categorie
Healthcare
EPS voor Haisco Pharmaceutical Group Co., Ltd. (002653)
EPS per June 2026 TTM: $0.13
Volgens de laatste financiële rapporten en de aandelenkoers van Haisco Pharmaceutical Group Co., Ltd. is de huidige EPS van het bedrijf (TTM) $0.13. Eind 2023 had het bedrijf een EPS van $0.04, gelijk aan de EPS van 2022 die $0.04 bedroeg.
EPS-geschiedenis van Haisco Pharmaceutical Group Co., Ltd. van 2008 tot 2026
EPS aan het einde van elk jaar
| Jaar | EPS | Wijzigen |
|---|---|---|
| 2026 (TTM) | $0.13 | 155.00% |
| 2024 | $0.05 | 27.03% |
| 2023 | $0.04 | 2.14% |
| 2022 | $0.04 | -25.99% |
| 2021 | $0.05 | -44.68% |
| 2020 | $0.09 | 37.82% |
| 2019 | $0.07 | 46.56% |
| 2018 | $0.05 | 33.43% |
| 2017 | $0.03 | -42.81% |
| 2016 | $0.06 | 9.65% |
| 2015 | $0.05 | -20.50% |
| 2014 | $0.07 | -14.29% |
| 2013 | $0.08 | 20.40% |
| 2012 | $0.07 | 29.33% |
| 2011 | $0.05 | 4.74% |
| 2010 | $0.05 | 6.83% |
| 2009 | $0.05 | 47.40% |
| 2008 | $0.03 | 0.00% |
EPS van vergelijkbare bedrijven of concurrenten
| Bedrijf | EPS | EPS-verschil | Land |
|---|---|---|---|
| $17.32 | 13,484.31% |
US
|
|
| $-7.98 | -6,358.82% |
US
|
|
| $-5.29 | -4,249.02% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | 21,656.86% |
NL
|
